Articles From: Sapiens to Announce Fourth Quarter and Annual 2014 Financial Results on February 25, 2015 to Sasol Limited: Change to Dividend Policy and Segmental Reporting


2015/1/28
HOLON, Israel , January 28, 2015 /PRNewswire/ -- Sapiens International Corporation , (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector, announced today that it will report its financial results for the fourth quarter and year that ended on December 31, 2014 on Wednesday, February 25, 2015 .
Sign-up for Sapiens to Announce Fourth Quarter and Annual 2014 Financial Results on February 25, 2015 investment picks
2014/12/16
HOLON, Israel , December 16, 2014 /PRNewswire/ -- Sapiens International Corporation (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector, announced today that the company will present at the 17 th annual Needham Growth Conference, to be held at The New York Palace hotel in New York City on January 13-15, 2015 .
Sign-up for Sapiens to Present at the 17th Annual Needham Growth Conference investment picks
2015/1/29
Sapient Global Markets , a division of Sapient (NASDAQ: SAPE), and leading global provider of business technology and consulting services for the capital and commodity markets, today announced the findings of a new survey it conducted examining industry attitudes towards changes in derivatives clearing.
Sign-up for Sapient Global Markets Survey Reveals Industry Concerns Surrounding Derivatives Clearing investment picks
2015/1/7
SapientNitro , part of Sapient® (NASDAQ: SAPE), today announced that top independent research firm Gartner, Inc. has positioned the agency as a Leader in its “Magic Quadrant for Global Digital Marketing Agencies 1 .” This is the third consecutive year that SapientNitro has been positioned in the Leaders quadrant.
Sign-up for SapientNitro Named a Leader for Third Consecutive Year in 2014 Gartner Evaluation of Global Digital Marketing Agencies investment picks
2014/12/8
SapientNitro , part of Sapient® (NASDAQ:SAPE), today announced that is has been named a leader in Forrester Research, Inc.’s December 2014 report: “The Forrester Wave™: Innovation Agencies, Q4 2014.” Forrester selected for participation in this Wave the 10 most significant agencies.
Sign-up for SapientNitro Named an Innovation Agency Leader by Independent Research Firm investment picks
2015/2/6
http://www.ccnmatthews.com/logos2/saputo.gif MONTREAL, QUEBEC --
Sign-up for Saputo Announces a Change in Senior Management investment picks
2015/2/2
http://www.ccnmatthews.com/logos2/saputo.gif MONTREAL, QUEBEC --
Sign-up for Saputo Completes the Sale of its Bakery Division investment picks
2015/1/13
http://www.ccnmatthews.com/logos2/saputo.gif MONTREAL, QUEBEC --
Sign-up for Saputo Inc./Fiscal 2015 Third Quarter Results: Conference Call and Webcast for Analysts and Institutional Investors investment picks
2014/12/18
http://www.ccnmatthews.com/logos2/saputo.gif MONTREAL, QUEBEC --
Sign-up for Saputo to Sell its Bakery Division investment picks
2015/2/16
MobileSmith is thrilled to announce the launch of Sarasota Memorial Health Care System’s hospital wayfinding app , created and published by its customer Sarasota Memorial using the MobileSmith app development platform.
Sign-up for Sarasota Memorial uses MobileSmith to Build and Launch Hospital Wayfinding App investment picks
2015/1/14
NEW YORK , Jan.
Sign-up for Saratoga Investment Corp. Announces Fiscal Third Quarter 2015 Financial Results investment picks
2014/12/16
NEW YORK , Dec.
Sign-up for Saratoga Investment Corp. to Report Fiscal Third Quarter 2015 Financial Results and Hold Conference Call investment picks
2015/1/14
Sarepta Therapeutics Inc. (NASDAQ: SRPT), a developer of RNA-based therapeutics, today announced that it has initiated dosing of SRP-4053 in its first human trial, a Phase I/II study in Duchenne muscular dystrophy (DMD). This multiple-dose study will assess the safety, tolerability, efficacy, and pharmacokinetics of SRP-4053 in DMD patients with genotypes amenable to exon-53 skipping.
Sign-up for Sarepta Therapeutics Announces First Patient Dosed in European Phase I/II Study of SRP-4053 in Duchenne Muscular Dystrophy Patients investment picks
2015/1/12
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a developer of innovative RNA-based therapeutics, today announced data through Week 168 from Study 202, a Phase IIb open-label extension study of eteplirsen in patients with Duchenne muscular dystrophy (DMD). After more than three years of treatment, results of the 6-minute walk test (6MWT) at 168 weeks showed continued ambulation across all patients evaluable on the test, however all patients showed a decline in distance walked on this measure since the week 144 timepoint.
Sign-up for Sarepta Therapeutics Reports Long-Term Outcomes through 168 Weeks from Phase IIb Study of Eteplirsen in Duchenne Muscular Dystrophy investment picks
2015/2/19
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, will report fourth quarter and full-year 2014 financial results before the NASDAQ Global Market opens on Thursday, February 26, 2015.
Sign-up for Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2014 Financial Results and Corporate Update on February 26, 2015 investment picks
2015/1/5
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today announced that it is scheduled to present at the 33 rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Thursday, January 15, 2015 at 12:00 p.m. PST.
Sign-up for Sarepta Therapeutics to Present Company Overview at the 2015 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/2/4
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a developer of innovative RNA-based therapeutics, today announced that management is scheduled to participate in fireside chats at the following investor conferences in February.
Sign-up for Sarepta Therapeutics to Present Company Overview at Upcoming Conferences investment picks
2015/2/24
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a developer of innovative RNA-based therapeutics, today announced that management is scheduled to present a company overview at the following investor conferences in March.
Sign-up for Sarepta Therapeutics to Present Company Overview at Upcoming Conferences investment picks
2015/1/7
Former United States Securities and Exchange Commission attorney Willie Briscoe , founder of The Briscoe Law Firm, PLLC , and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit has been filed in the United States District Court for the Southern District of New York against Sarepta Therapeutics, Inc. (“Sarepta”) (NASDAQ: SRPT) and several officers and directors for acts taken during the period of April 21, 2014 to October 27, 2014 (the “Class Period”). Based upon the allegations in the class action, the firms are investigating additional legal claims against the officers and Board of Directors of Sarepta.
Sign-up for Sarepta Therapeutics, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors investment picks
2015/1/12
ATLANTA , Jan.
Sign-up for Sarvint Technologies Files Complaints for Patent Infringement for Wearable Technology investment picks
2015/2/19
SAS Announces Appointments of New Chairman of the Board and New Director Canada NewsWire TORONTO , Feb.
Sign-up for SAS Announces Appointments of New Chairman of the Board and New Director investment picks
2015/2/18
SAS Announces Resignation of Chair of the Board Canada NewsWire TORONTO , Feb.
Sign-up for SAS Announces Resignation of Chair of the Board investment picks
2015/1/27
SAS releases preliminary results of the second bulk sample from Taylor Advanced Exploration Project Canada NewsWire TORONTO , Jan.
Sign-up for SAS releases preliminary results of the second bulk sample from Taylor Advanced Exploration Project investment picks
2015/2/12
SAS reports 2014 fourth quarter and year end results, increases reserves and resources, and announces a positive production decision for the Taylor Project Canada NewsWire All dollar amounts are stated in Canadian dollars, unless otherwise indicated TORONTO , Feb.
Sign-up for SAS reports 2014 fourth quarter and year end results, increases reserves and resources, and announces a positive production decision for the Taylor Project investment picks
2014/12/22
JOHANNESBURG and LAKE CHARLES, Louisiana , December 22, 2014 /PRNewswire/ -- Sasol Limited (Sasol) (JSE: SOL; NYSE: SSL) today announced the completion of a US$4 billion credit facility for its ethane cracker and derivatives at its existing site in Lake Charles, Louisiana .
Sign-up for Sasol Announces Completion of US$4 Billion Credit Facility for its World-Scale Ethane Cracker and Derivatives Complex in Louisiana investment picks
2015/1/28
JOHANNESBURG , January 28, 2015 /PRNewswire/ -- Sasol (JSE:SOL, NYSE:SSL) announced that it is formulating a comprehensive plan to conserve cash in response to lower international oil prices.
Sign-up for Sasol Announces Plan to Respond to the Low Oil Price Environment investment picks
2015/2/6
By Rory Gallivan LONDON--South African energy group Sasol Ltd.
Sign-up for Sasol First-Half Earnings to Rise, Low Oil Price to HurtFY investment picks
2015/2/2
JOHANNESBURG , February 2, 2015 /PRNewswire/ -- Sasol Limited (JSE: SOL; NYSE: SSL) will today be hosting analysts and investors at its Westlake facility in Lake Charles, Louisiana .
Sign-up for Sasol Hosts an Investor Visit to its US Ethane Cracker and Derivatives Project investment picks
2015/2/9
JOHANNESBURG , February 9, 2015 /PRNewswire/ -- Sasol Limited ("Sasol" or "the Company") Sasol (JSE:SOL, NYSE:SSL) today announced a change in the executive responsibilities of executive director, Ms V N Fakude, who currently has accountability for the Sustainability and Human Resources portfolio, and the soon to be appointed executive director, Mr B Nqwababa, who will be joining Sasol as its new Chief Financial Officer on 1 March 2015 .
Sign-up for Sasol Limited: Change in Directors' Executive Responsibilities and Optimised Top Managament Structure Announced investment picks
2015/2/18
JOHANNESBERG, February 18, 2015 /PRNewswire/ -- In response to the current low oil price environment, an initiative to conserve cash over the next 30 months was announced by Sasol on 28 January 2015 ("Response Plan"). Sasol's Response Plan comprises 5 key components, namely: capital portfolio phasing and reductions; capital structuring; working capital improvements; margin enhancement; and further cash cost reductions, supplementing the Group's target of at least R4 billion annual costs savings driven through the company-wide business performance enhancement programme, which was launched in 2013.
Sign-up for Sasol Limited: Change to Dividend Policy and Segmental Reporting investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Sapiens to Announce Fourth Quarter and Annual 2014 Financial Results on February 25, 2015 to Sasol Limited: Change to Dividend Policy and Segmental Reporting
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent